Active, not recruitingPhase 3NCT04821622
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Studying Multiple endocrine neoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Pfizer CT.gov Call CenterPfizer
- Intervention
- talazoparib plus enzalutamide(drug)
- Enrollment
- 599 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2021 – 2027
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Arizona Institute of Urology, PLLC, Tucson, Arizona, United States
- Beverly Hills Cancer Center, Beverly Hills, California, United States
- Adventist Health Glendale, Glendale, California, United States
- VA Long Beach Healthcare System, Long Beach, California, United States
- Yale-New Haven Hospital, New Haven, Connecticut, United States
- MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
- Washington Cancer Institute at MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- AdventHealth Medical Group Hematology and Oncology, Orlando, Florida, United States
- Investigational Drug Services, Advent Health Orlando, Orlando, Florida, United States
- Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital, Austell, Georgia, United States
- Wellstar Cobb Hospital, Austell, Georgia, United States
- Northwest Georgia Oncology Centers, a Service of Tanner Medical Center Villa Rica, Carrollton, Georgia, United States
- West Georgia Infusion Center, a Service of Tanner Medical Center Villa Rica, Carrollton, Georgia, United States
- Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital, Cartersville, Georgia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Astellas Pharma Inc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04821622 on ClinicalTrials.govOther trials for Multiple endocrine neoplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07521436Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and MenIstituti Clinici Scientifici Maugeri SpA
- RECRUITINGEARLY PHASE1NCT06888102A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate CancerEdwin Posadas, MD
- RECRUITINGNANCT07499167BRAHMS: Bed Rest And HypoMetabolism StudyCentre National d'Etudes Spatiales
- RECRUITINGPHASE1NCT07304128A Study of PLB-002 in Advanced Solid TumorsPrimelink BioTherapeitics(ShenZhen) Limited
- ACTIVE NOT RECRUITINGNCT07518212OST and MORES in Male OsteoporosisKayseri City Hospital
- RECRUITINGNANCT07187518Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound DevicePOROUS GmbH
- RECRUITINGPHASE4NCT07397403The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.Bangrak STIs Center
- RECRUITINGNANCT07217834Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and WomenPepsiCo Global R&D